Seoochre

Big pharma is gradually and progressively riding the social media bandwagon with a host of tactics towards listening, analytics, engagement, brand promotions, and much more. This has meant successful handling of the regulatory hurdles — what to share, what not to share, how much to share and most importantly the safety events that need to be reported. But even as all of this is afoot, companies are generally observed to be reticent in embracing social media wholeheartedly. While companies in other industries may only fret over a social media faux pas because it can potentially lead to public

As is the case in most scientific disciplines, the most common way to determine how something works is to break it down, identify and quantify its component parts and then see how they work together to function as a whole. This is true for understanding the metabolism of a cell, for understanding the synthesis of a chemical, and in the pharmaceutical industry, for understanding the formulation and function of reference listed drugs (RLDs).

The reverse engineering of an RLD—product deformulation—is a critical step in the development of more accessible and less expensive generic versions. De

Nanomaterials have been one of the most exciting scientific and technical innovations of the past few decades. Due to their very high surface to volume ratios, they exhibit properties that can differ dramatically from those for the same material in bulk. This, and their ability to be designed and synthesized with multiple surface functionalities, has seen them used for a myriad of bespoke applications in industry and medicine.

Their medical applications span delivery systems for drugs, proteins and DNA/RNA to diagnostics, targeted cancer treatments, to theranostics. They have been used ver

To bring this into reality, pharmaceutical PV organisations need to move into a “digitalised future” where technology plays a key role in PV processes. This includes automating and streamlining the information streams to reduce complexity, from case processing to reporting. Once automated, companies need to begin to look to artificial intelligence to add further value from their data.

By applying artificial intelligence (AI) and data science approaches, organisations can turn the overabundance of data from being a challenge to solve, into an opportunity. A well-designed, automated, AI-powe

Big pharma is gradually and progressively riding the social media bandwagon with a host of tactics towards listening, analytics, engagement, brand promotions, and much more. This has meant successful handling of the regulatory hurdles — what to share, what not to share, how much to share and most importantly the safety events that need to be reported. But even as all of this is afoot, companies are generally observed to be reticent in embracing social media wholeheartedly. While companies in other industries may only fret over a social media faux pas because it can potentially lead to public

While the life sciences sector has incrementally adopted digital technologies over the years, the rate of digital transformation over the next five years looks to be unprecedented. Collaborations and acquisitions in the pursuit of digital transformation have accelerated significantly. In 2018, US$9.5 billion was invested in the digital health sector over 698 deals. From the FDA approval of Otsuka’s sensor embedded drug Abilify Mycite and the approval of Pear Therapeutics’ app for the treatment of opioid abuse, through to Takeda’s partnership with Emulate Inc for the use of organs on chips for

In August 2021, ransomware operators targeted the health department of the Italian region of Lazio and disabled its COVID-19 vaccination booking system, disrupting the scheduling of new vaccination appointments for days.

Since it contains the city of Rome and is one of Italy’s most densely populated areas, Lazio was an attractive target because of the strong desire among its people to get vaccinated and gain its Green Pass vaccine passport. Hackers likely believed that this would pressure the authorities to pay up the ransom to unlock the systems they had disabled through a cyberattack.

However, these efforts are haunted by a shortage of resources, restrictions on importing API, social distancing at facilities, disturbed supply chains, and tremendous pressure to quickly manufacture and distribute products. Despite these arduous circumstances, it remains critical for pharma companies to maintain quality and compliance and follow regulatory guidelines. Doing so requires pertinent measures to ensure adherence to Current Good Manufacturing Practice (CGMP) guidelines, and data integrity to meet the requirements of regulators including the U.S. Food and Drug Administration (FDA),

The global pharmaceutical industry is currently facing many, wide ranging, challenges, including an aging population, increased life expectancy, a rise in chronic conditions, reduced funding for treatments, reduced numbers of clinical staff, the ever increasing cost of drug development and raw materials, and supply chain issues. Consequently, the pharmaceutical industry is increasingly looking at how a wealth of data, including compound libraries, trial data, and patient data, can be used and reused by artificial intelligence (“AI”) to alleviate these challenges and improve patient care.

Conventional dosage forms and delivery systems present several challenges in treatment of diseases like poor bioavailability, high dose, frequent administration, systemic adverse effects, etc. Also, increasing prevalence of chronic diseases, high demand for non-invasive administration of drugs, need for high bioavailability and targeted delivery of drugs for lesser side effects have paved the way for innovation in drug delivery systems. Therefore, pharmaceutical companies are focused on designing novel drug delivery systems to overcome the limitations of using conventional dosage forms. For t

A winning strategy is essential to reach or accomplish goals in pharmaceutical industry. However, maintaining the excellence of Strategic Drug Development Services is a necessary stipulation for the Strategic evolution for Pharma companies. The technologies leading to Pharmaceutical regulatory strategy and Pharmaceutical strategic developments are at the limits of human knowledge. The huge size of the companies, organizations and the complexities of their technologies and processes present many challenges. On the other hand, strategy development and distribution system is highly costly to imp

Research & Development is essential in all industries. And, when it comes to the Biopharmaceutical research industry, R&D services not only generates income for the companies involved in the research but it often brings results in lives being saved, or at least enhancement in patient's lives. The development for many companies requires the perfect Pharmaceutical research & development. There has been a great deal of research and development in this industry by the doctors and scientists all over the world. Reliable Pharmaceutical R&D services allow companies to follow manufacturing procedures

Clinical trials industry is constantly evolving, and also new clinical studies are being launched at an ever-growing pace. Clinical trial services have widely regarded as the principal method for obtaining a reliable evaluation of treatment effect on patients. Conducting clinical trials is a growing trend in the medical industry for testing the safety level and effectiveness of a newly developed medical device or drug. They provide the reliable basis for evaluating the efficacy and safety of new treatments in clinical trials industry. The historical perspective, present status, and future str

Pharma Manufacturing practices include all methods that are required to develop Pharma services. These practices provide minimum requirements that must and should be met by pharmaceutical companies in order to provide high-quality products that will pose no risk to the patients/consumers at large. Pharmaceutical contract manufacturing process involves Pharmaceutical machinery, drug manufacturers contracting a firm for finished products or components. It can be seen as a type of outsourcing. Organizations succeed by focusing on what they do best to their consumers, partners or outsourced vendo

The pharmaceutical industry demands a winning approach if you want to accomplish your goals. Pharmaceutical companies are required to develop effective drug development services as part of their evolution. The pharmaceutical industry is at the forefront of human knowledge when it comes to regulatory strategy and strategic developments. Businesses and organizations face many challenges due to their size and complexity. Conversely, implementing strategic development and distribution networks is very expensive. For this reason, effective pharmaceutical strategies are critical to achieving long-t

The field of clinical trials is continually changing, and more and more new clinical research is being published. The primary approach for gaining an accurate assessment of a treatment's impact on patients is usually recognized as clinical trial services. A developing trend in the medical sector is the use of clinical trials to evaluate the degree of safety and efficacy of newly discovered drugs and medical devices. They offer the clinical trials industry a trustworthy platform for assessing the safety and efficacy of novel medicines. A context-giving framework is provided by the historical p

Pharma manufacturing techniques necessary to create pharmaceutical services are included in manufacturing processes. These procedures outline the minimal standards that pharmaceutical firms must and ought to meet to deliver high-caliber goods that don't endanger patients or consumers as a whole. Drug makers hire a company to produce completed goods or parts using pharmaceutical machinery in the pharmaceutical contract manufacturing process. It might be considered a form of outsourcing. Focusing on what they do best for customers, partners, or external vendors is how businesses flourish. Contr

Organizations can operate more productively and effectively thanks to information technology. The preservation of records, quicker communication, and electronic storage are the main benefits. Pharmaceutical IT services are available to businesses of all sizes and can assist in overcoming the difficulties associated with drug development. The development of pharmaceutical ERP software has made it simple to run your company more effectively. Pharmaceutical software solutions are easy to install and aid firms in efficiently meeting standards. They can raise the calibre of the goods. Information

To achieve its goals, the pharmaceutical industry needs a winning strategy. As part of their evolution, pharmaceutical companies must expand their powerful drug improvement offers. In terms of a regulatory framework and tactical innovations, the pharmaceutical industry is at the cutting edge of human knowledge. The length and complexity of these situations make them challenging for businesses and agencies. On the other hand, implementing distribution and enhancement networks may be quite expensive. Strong pharmaceutical techniques are essential to achieving long-term success since they enable

Clinical trials are a constantly evolving field, and more and more relevant scientific research is being published. Clinical trial services are frequently cited as the most reliable method for accurately assessing a treatment's impact on patients. Utilizing clinical trials to evaluate the safety and effectiveness of recently developed medications and medical devices is a growing practice in the healthcare field.They offer a reliable platform for the clinical trials sector to evaluate the efficacy and safety of innovative medications. Through the historical history, current situation, and clin